HUNTINGTON NATIONAL BANK - VIROPHARMA INC ownership

VIROPHARMA INC's ticker is VPHM and the CUSIP is 928241108. A total of 1 filers reported holding VIROPHARMA INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
HUNTINGTON NATIONAL BANK ownership history of VIROPHARMA INC
ValueSharesWeighting
Q3 2023$500.0%10.0%0.00%
Q2 2023$500.0%10.0%0.00%
Q1 2023$500.0%10.0%0.00%
Q4 2022$5010.0%0.00%
Q3 2022$010.0%0.00%
Q2 2022$010.0%0.00%
Q1 2022$010.0%0.00%
Q4 2021$010.0%0.00%
Q3 2021$010.0%0.00%
Q2 2021$010.0%0.00%
Q1 2021$010.0%0.00%
Q4 2020$010.0%0.00%
Q3 2020$010.0%0.00%
Q2 2020$010.0%0.00%
Q1 2020$010.0%0.00%
Q4 2019$010.0%0.00%
Q3 2019$010.0%0.00%
Q2 2019$010.0%0.00%
Q4 2018$010.0%0.00%
Q3 2018$0
-100.0%
1
-99.8%
0.00%
Q1 2011$11,000
+22.2%
5300.0%0.00%
Q4 2010$9,000
+12.5%
5300.0%0.00%
Q3 2010$8,000
+33.3%
530
-7.5%
0.00%
Q2 2010$6,000
-81.2%
573
-75.4%
0.00%
-100.0%
Q1 2010$32,000
+68.4%
2,3300.0%0.00%0.0%
Q4 2009$19,000
-13.6%
2,3300.0%0.00%0.0%
Q3 2009$22,000
+57.1%
2,3300.0%0.00%0.0%
Q2 2009$14,000
+16.7%
2,3300.0%0.00%0.0%
Q1 2009$12,0002,3300.00%
Other shareholders
VIROPHARMA INC shareholders Q3 2020
NameSharesValueWeighting ↓
Palo Alto Investors LP 3,093,291$121,443,00012.73%
Tamarack Capital Management, LLC 350,000$13,741,0003.64%
Baker Brothers Advisors 5,592,239$219,551,0003.12%
SHIKIAR ASSET MANAGEMENT INC 131,000$5,143,0002.56%
Tygh Capital Management, Inc. 202,048$7,932,0001.78%
Healthcare Value Capital, LLC 50,000$1,963,0001.72%
PRICE MICHAEL F 292,500$11,484,0001.53%
PointState Capital LP 2,217,200$87,047,0001.49%
Pentwater Capital Management LP 1,250,000$49,075,0001.36%
WCM INVESTMENT MANAGEMENT, LLC 662,263$25,989,0001.36%
View complete list of VIROPHARMA INC shareholders